Keywords: Human iPSC-derived cortical neurons; Multi-electrode array; Synchronized burst firing; 4-step method; hiPSC; human induced pluripotent stem cell; MEA; multi-electrode array; SBF; synchronized burst firing; DIV; days in vitro; WIV; weeks in vitro; TIT; t
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: hiPSC; hMSC; Downstream process; Cell decay kinetics; Cryopreservation solution; Lot size;
Keywords: T1DM; Type 1 diabetes mellitus; EDS; Search E-Resources; IGF1; insulin-like growth factor 1; NOD; non-obese diabetic; G6Pase; glucose-6-phosphatase; HGF; hepatocyte growth factor; SCID; severe combined immunodeficiency; BTC; betacellulin; Ngn3; Neurogenin
Keywords: hPSC; human pluripotent stem cell; hiPSC; human induced pluripotent stem cell; NPC; neuronal progenitor cell; hPSC-NPC; human pluripotent stem cell derived neuronal progenitor cell; EB; embryoid body; CNS; central nervous system; DG; dentate gyrus; GECI;
Keywords: SFEB; serum free floating embryoid body like aggregates; RG; radial glia; hcNPC; human cortical neuronal progenitor cells; hiPSC; human induced pluripotent stem cell; Cerebral organoid; Cortical neuron; Induced pluripotent stem cells; Radial migration;
Keywords: Autophagy; hiPSC; Mitochondria; Cardiomyocyte; Heart failure;
Keywords: ACh; acetylcholine; ANOVA; analysis of variance; AP; action potential; APD; action potential duration; ECG; electrocardiogram; EFS; electrical field stimulation; hiPSC; human induced pluripotent stem cell; nAChRs; nicotinic acetylcholine receptors; RTG; r
Keywords: AD; Alzheimer's disease; NFT; neurofibrillary tangles; hiPSC; human induced pluripotent stem cell; PHF; paired helical filament; FTD; frontotemporal dementia; NDC; non-demented control; PS-1; presenilin 1; YFP; yellow fluorescent protein; Tau; Neurofibril
Keywords: Cerebellum; Cortex; Glucose; Glutamate; Glutamine; hiPSC; Mitochondria; Neurons; AMPA; α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid; α-KG; α-ketoglutarate; Ac-CoA; Acetyl-CoA; bFGF; Basic fibroblast growth factor; BSA; bovine serum albumin; BN
Keywords: Human induced pluripotent stem cell-derived cardiomyocyte; Sympathetic neuron; Co-culture; Microelectrode array; Microdevice; hPSC; human pluripotent stem cell; hiPSC; human induced pluripotent stem cell; hiPSCM; human induced pluripotent stem cell-derive
Keywords: 2D; two dimensional; 2PP; two-photon hydrogel polymerization; 3D; three-dimensional; AFM; atomic force microscopy; AgNP; silver nanoparticles; AuNP; gold nanoparticle; α-SMA; alpha-smooth muscle actin; RGD; Arg-Gly-Asp; BMP; bone morphogenetic protein; C
Keywords: Neurotrophin; Jiadifenolide; hiPSC; Neurite outgrowth; MAP2; PSD95;
Keywords: BAK; BCL-2 antagonist killer; BAX; BCL-2 associated X protein; CDK1; cyclin dependent kinase 1; CLDN-6; claudin-6; CM; cardiomyocyte; CPE; Clostridium perfringens endotoxin; GPX2; glutathione peroxidase-2; GSH; glutathione; GSR; glutathione reductase; GSS
Keywords: Cardiomyocyte; Delayed repolarization; Drug safety; Induced pluripotent stem cell; Methods; Proarrhythmic risk; Rate correction algorithm; ECG; electro cardiogram; hiPSC; human induced pluripotent stem cells; MEA; multi-electrode array; QT; time interval
Keywords: AAV; adeno-associated virus; CM; cardiomyocyte; EHT; engineered heart tissue; ESC; embryonic stem cell; hEHT; human engineered heart tissue; hESC; human embryonic stem cell; hiPSC; human induced pluripotent stem cell; HLA; human leucocyte antigen; hNT-ESC
Keywords: iPSC; induced pluripotent stem cell; hiPSC; human induced pluripotent stem cell; iPSC-EC; induced pluripotent stem cell-derived endothelial cell; EC; endothelial cell; HCAEC; human coronary artery endothelial cells; vWF; von Willebrand factor; Ac-LDL; ace
Keywords: Extracellular matrix; Human embryonic stem cell; Human induced pluripotent stem cell; Hepatic differentiation; Laminin-511; Laminin-521; ACM; acellular matrix; Act A; Activin A; AAT; alpha-1 antitrypsin; AFP; alpha fetoprotein; ALB; albumin; AhR; aryl hyd
Keywords: Individualized therapy; PBPK models; hiPSC; Heart disease; Children; Pharmacogenetics
Keywords: cTnT; cardiac specific troponin T; hESC; human embryonic stem cells; hiPSC; human induced pluripotent stem cells; hPSC; human pluripotent stem cells; LDH; lactate dehydrogenase; SAM; statistical analysis of microarray; Human pluripotent stem cells; Cardio
Keywords: Human induced pluripotent stem cells (hiPSCs); Endothelial cells; Shear stress; Bioreactor; Arterial; Vascular tissue engineering; hiPSC; human induced pluripotent stem cells; hiPSC-EC; human iPSC-derived endothelial cells; HUVEC; human umbilical cord vei
Keywords: hIPSC; Liver; Stem cells; Lipid disorders; Human development; Disease modeling
Keywords: CNQX; 6-cyano-7-nitroquinoxaline-2,3-dione; DIV; days in vitro; hiPSC; human induced pluripotent stem cell; MEA; multi-electrode array; PBS; phosphate-buffered saline; Astrocyte co-culture; Human induced pluripotent stem cell-derived neurons; Long-term me
Keywords: cp-p; continuously paced group-paced state; cp-s; continuously paced group-spontaneous state; EC50; half maximal effective concentration; ECM; extracellular Matrix; EHT; engineered heart tissue; FC; fold change; FS; fractional shortening; hEHT; human engi
Keywords: BCRP; breast cancer resistance protein; BSEP; bile salt export pump; BSP; bromosulfophtalein; CYP; cytochrome P450; day 29 or 36; hepatocyte cultures 29 or 36 days respectively after start of the hepatic differentiation protocol; E17βG; estradiol-17β-d-
A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres
Keywords: hiPSC; human induced pluripotent stem cell; CM; cardiomyocyte; BL; BioLevitator; HD; hanging drop; NC; NucleoCounter; LT; LeviTube; Ca; Calcein; hiPSCs; Cardiomyocytes; Cardiac induction; 3D bioreactor; Papain dissociation;
NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populations
Keywords: Human induced pluripotent stem cells; NKX6.1; Reporter cell line; Directed differentiation; hiPSC-derived beta cells; EBiSC; European Bank for Induced Pluripotent Stem Cells; FACS; Fluorescence activated cell sorting; GFP; Green fluorescence protein; GSIS
Cross - site comparison of excitation-contraction coupling using impedance and field potential recordings in hiPSC cardiomyocytes
Keywords: Arrhythmia; EAD; CardioExcyte 96; Cardiomyocytes; CiPA; Contractility; Extracellular field potential; hiPSC; Impedance; Safety pharmacology; AXG; Cor.4U®, hiPSC-CMs, Ncardia; BrCoV; Beat rate (beat period) coefficient of variation; CDI; iCell Cardiomyocy
Comparison of the acute inhibitory effects of Tetrodotoxin (TTX) in rat and human neuronal networks for risk assessment purposes
Keywords: ARfD; acute reference dose; DIV; days in vitro; EFSA; European Food Safety Authority; FBS; fetal bovine serum; hIPSC; human-induced pluripotent stem cell; IC50; half maximal inhibitory concentration; LD50; median lethal dose; LOEAL; lowest observed advers
CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response
Keywords: CXCR4; CXCR7; Cardiogenesis; hiPSC; Engineered tissue; hiPSC; human induced pluripotent stem cell; hiPSC-CM; human induced pluripotent stem cell-derived cardiomyocyte; hECT; human engineered cardiac tissue; GPCR; G-protein coupled receptor; SDF-1; stromal
Sensitivity of hiPSC-derived neural stem cells (NSC) to Pyrroloquinoline quinone depends on their developmental stage
Keywords: Mitochondrial biogenesis; PQQ; Developmental neurotoxicity; Neural stem cells; Neural progenitors; hiPSC;
Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters
Keywords: Brugada syndrome; hiPSC-cardiomyocytes; Ajmaline; INa; IKr; Activation-recovery interval; AP; Action Potential; APD; Action Potential Duration; Br1; Brugada Type 1 ECG; BrS; Brugada Syndrome; cFPD; Corrected Field Potential Duration (Bazett's formula); CM
Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms
Keywords: hiPSC; human induced pluripotent stem cell; CNV; Copy number variation; SNP; Single nucleotide polymorphism; PPI; Paired pulse inhibition; Schizophrenia; CNV; Mouse models; Hipsc models;
Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes
Keywords: Cardiotoxicity; Action potential; Quinidine; Verapamil; CMOS-MEA; Intracellular recording; hiPSC;
Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells
Keywords: Neural induction; Neural progenitor cells; hiPSC; Electron microscopy; Patch clamp; 2D-3D neural induction; AD; Alzheimer's disease; AQP4; Aquaporin 4; ASD; Autism spectrum disorder; bFGF; Basic Fibroblast Growth Factor; CNS; Central Nervous System; D; Da
Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function
Keywords: PSC-Based Model; Neural Development; Enteric Nervous System; Congenital; CD; coding; CNS; central nervous system; CRISPR; clustered regularly interspaced short palindromic repeats; ENCC; enteric neural crest cell; FA; focal adhesion; GDNF; glial cell-deri
LncRNA MIAT: Myocardial infarction associated and more
Keywords: lncRNA; long non-coding RNA; MIAT; myocardial infarction associated transcript; SNP; single nucleotide polymorphism; ORF; open reading frame; LD; linkage disequilibrium; LV; left ventricular; CAD; coronary artery disease; MI; myocardial infarction; STEMI;
Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging
Keywords: CiPA; Comprehensive in vitro Proarrhythmia Assay; TdP; Torsades de Pointes; AP; action potential; CT; Ca2Â + transient; hiPSC; human induced pluripotent stem cell; CM; cardiomyocyte; CaViar; Ca2Â + and voltage indicator; CheRiff; channelrhodopsin variant;
Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells
Keywords: hiPSCs; human induced pluripotent stem cells; NPCs; neural progenitor cells; Ngn2; Neurogenin 2; SZ; schizophrenia; GFP; green florescent protein; PuroR; puromycin resistance; hiPSC; Directed differentiation; Neuronal induction; iNeuron; Modeling neuropsy
Tumorigenicity assessment of human cell-processed therapeutic products
Keywords: Cell therapy; Pluripotent stem cells; Quality control; Regenerative medicine; Somatic stem cells; Tumorigenicity tests; AMD; age-related macular degeneration; hCTP; human cell-processed therapeutic product; hESC; human embryonic stem cell; hiPSC; human in
Evaluation of established human iPSC-derived neurons to model neurodegenerative diseases
Keywords: HEPES; 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; iPSC; induced pluripotent stem cells; disease modeling; neurodegeneration; hiPSC; GABAergic neuron;
Onset of rosette formation during spontaneous neural differentiation of hESC and hiPSC colonies
Keywords: hESCs; human embryonic stem cells; hiPSC; human induced pluripotent stem cell; NOD-SCID; non-obese diabetes-severe combined immunodeficiency; EB; embryoid bodies; NEC; primitive neuroectoderm; NP; neural progenitors; RNSC; Rosette neural stem cell line; G
Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes
Keywords: Ad; adenovirus; AP; action potential; CM; cardiac myocyte; ESC; embryonic stem cell; FACS; fluorescence-activated cell sorting; GFP; green fluorescent protein; hiPSC; human induced pluripotent stem cell; MLC-2ap; myosin light chain-2 atrial promoter; MLC-
Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine
Keywords: hESC; hiPSC; Beta cell; Diabetes; Directed differentiation;
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies
Keywords: AFP; alpha fetoprotein; Alb; albumin; ATP5g1; mitochondrial F0 complex, subunit C1 (subunit 9), ATP synthase 5 subunit e; ATP8; ATP synthase 8; BAL; bioartificial liver; BMP4; bone morphogenetic protein 4; CYP; cytochrome P450; CYP2C19; CYP Family 2, Subf